Postersession 4
Hemotherapy | Immunohematology

Programm

• 16:30 – 16:32 2 Min. 0 Min.

  • ePoster
  • PS-4-1

  Peripartum blood component management of severe IgA-deficient patient

  • Dr. Diana Maria Vajcs (Munich/ DE)

   Hemotherapy
• 16:32 – 16:34 2 Min. 0 Min.

  • ePoster
  • PS-4-2

  Ramipril-induced shock during therapeutic leukapheresis

  • Dr. Hella Pfeiffer (Erlangen/ DE)

   Hemotherapy
• 16:34 – 16:36 2 Min. 0 Min.

  • ePoster
  • PS-4-3

  Red blood cell usage in a tertiary care hospital during the COVID-19 pandemic

  • Prof. Dr. Robert Zimmermann (Erlangen/ DE)

   Hemotherapy
• 16:36 – 16:38 2 Min. 0 Min.

  • ePoster
  • PS-4-4

  TIMMY (Transfusionsmedizin-Training mit Dummys) – a novel concept for practical education in transfusion medicine using blood product dummys

  • Dr. Jürgen Kößler (Würzburg/ DE)

   Hemotherapy
• 16:38 – 16:40 2 Min. 0 Min.

  • ePoster
  • PS-4-5

  Autologous transfusion of cryopreserved platelets in a CD36-negative patient after allogeneic stem cell transplantation

  • Dr. Daniel Kownatzki-Danger (24105/ DE)

   Hemotherapy
• 16:40 – 16:42 2 Min. 0 Min.

  • ePoster
  • PS-4-6

  Successful erythrocytapheresis in patients with hereditary hemochromatosis

  • Dr. Irene Pamler (Regensburg/ DE)

   Hemotherapy
• 16:42 – 16:44 2 Min. 0 Min.

  • ePoster
  • PS-4-7

  Characteristics of red cell transfusion dependent outpatients: a single center experience

  • Dr. Sixten Körper (Ulm/ DE)

   Hemotherapy
• 16:44 – 16:46 2 Min. 0 Min.

  • ePoster
  • PS-4-8

  Intrauterine blood transfusion for maternal red-cell alloimmunization - a single center experience

  • Dr. Stefanie Nowak-Harnau (Tübingen/ DE)

   Hemotherapy
• 16:46 – 16:48 2 Min. 0 Min.

  • ePoster
  • PS-4-9

  Influence of corona pandemic on error frequency in hemotherapy

  • Romy Winter (Dresden/ DE)

   Hemostaseology
• 16:48 – 16:50 2 Min. 0 Min.

  • ePoster
  • PS-4-10

  Use of the Spectra Optia RBC exchange module to induce experimental severe normovolemic anemia

  • Dr. Anna-Lena Semmler (Frankfurt am Main/ DE)

   Hemotherapy
• 16:50 – 16:52 2 Min. 0 Min.

  • ePoster
  • PS-4-11

  Molecular testing for Rhesus D antigen (RhD) in patients with ambiguous results in serological testing for RhD: implications for transfusion strategy

  • PD Dr. David Juhl (Lübeck/ DE)

   Immunohematology
• 16:52 – 16:54 2 Min. 0 Min.

  • ePoster
  • PS-4-12

  Development of multiplex TaqMan probe PCR Assays for typing of up to 6 genetic markers per reaction

  • Gabriele Rink (Mannheim/ DE)

   Immunohematology
• 16:54 – 16:56 2 Min. 0 Min.

  • ePoster
  • PS-4-13

  Molecular blood typing of patients with Sickle Cell disease in Germany

  • Marie Kuhn (Mannheim/ DE)

   Immunohematology
• 16:56 – 16:58 2 Min. 0 Min.

  • ePoster
  • PS-4-14

  Compound heterozygosity for five different CD36 mutations induces CD36 type I deficiency in three members of a family of Arabian origin

  • Dr. Brigitte Flesch (Bad Kreuznach/ DE)

   Immunohematology
• 16:58 – 17:00 2 Min. 0 Min.

  • ePoster
  • PS-4-15

  A p.Leu319Pro missense mutation in ABO likely results in a non-deletional O allele

  • Dr. Nico Greger (Rostock/ DE)

   Immunohematology
• 17:00 – 17:02 2 Min. 0 Min.

  • ePoster
  • PS-4-16

  Routine testing for RHD*01W.1, RHD*01W.2 and RHD*01W.3 subtype alleles is dispensable in Switzerland

  • Dr. Bernd Schimanski (Bern/ CH)

   Immunohematology
• 17:02 – 17:04 2 Min. 0 Min.

  • ePoster
  • PS-4-17

  Characterization of two novel ABO splice site variations preventing blood group A and B expression

  • Dr. Sarah Petermann (Bad Kreuznach/ DE)

   Immunohematology
• 17:04 – 17:06 2 Min. 0 Min.

  • ePoster
  • PS-4-18

  First report of the rare RhCE-depleted D--phenotype in sixteen people of Iranian origin

  • Ehsan Shahverdi (Osnabrück/ DE)

   Immunohematology
• 17:06 – 17:08 2 Min. 0 Min.

  • ePoster
  • PS-4-19

  The first comprehensive study of H-deficient phenotypes in Iran

  • Ehsan Shahverdi (Osnabrück/ DE)

   Immunohematology
• 17:08 – 17:10 2 Min. 0 Min.

  • ePoster
  • PS-4-20

  First report of known rare rhnull phenotype individuals in Iran

  • Ehsan Shahverdi (Osnabrück/ DE)

   Immunohematology
• 17:10 – 17:12 2 Min. 0 Min.

  • ePoster
  • PS-4-21

  Maternal red blood cell alloantibodies identified in blood samples obtained from Iranian pregnant women: the first population study in Iran

  • Ehsan Shahverdi (Osnabrück/ DE)

   Immunohematology
• 17:12 – 17:14 2 Min. 0 Min.

  • ePoster
  • PS-4-22

  Red blood cell immunization and contributing factors in 685 Thalassemia patients

  • Ehsan Shahverdi (Osnabrück/ DE)

   Immunohematology
• 17:14 – 17:16 2 Min. 0 Min.

  • ePoster
  • PS-4-23

  Titer progression of two blood group alloantibodies under massive antibody-reducing chemo- and apheresis therapy

  • M.A. Marion Posset (Regensburg/ DE)

   Immunohematology
• 17:16 – 17:18 2 Min. 0 Min.

  • ePoster
  • PS-4-24

  Experience with a triple exon RHD-NIPT and detection of maternal and fetal RH variants

  • Dr. Lukas Wagner (Berlin/ DE)

   Immunohematology
• 17:18 – 17:20 2 Min. 0 Min.

  • ePoster
  • PS-4-25

  Transmission of anti-CD38 (Daratumumab) by autologous stem cell transplantation causes interference in immunohematological diagnostic

  • Dr. Kathrin Luckner (Lübeck/ DE)

   Immunohematology
• 17:20 – 17:22 2 Min. 0 Min.

  • ePoster
  • PS-4-26

  ABO splice-site variants encoding weak A and B phenotypes complicate pre-transfusion ABO blood group diagnostics

  • Maria Bemelmans (Graz/ AT)
  • Mag. Dr. Eva Maria Matzhold (Graz/ AT)

   Immunohematology
• 17:22 – 17:24 2 Min. 0 Min.

  • ePoster
  • PS-4-27

  The strong potential of the weakly positive DAT for alloantibody elution

  • Dr. Andrea Rosner (Dresden/ DE)

   Immunohematology
• 17:24 – 17:26 2 Min. 0 Min.

  • ePoster
  • PS-4-28

  Neutralization of Anti-CD38 in patient samples by a soluble CD38 protein to allow alloantibody detection procedures

  • Dr. Thomas Bise (Düdingen/ CH)

   Immunohematology
• 17:26 – 17:28 2 Min. 0 Min.

  • ePoster
  • PS-4-29

  Case report: Anti-U caused mild haemolytic disease of the newborn

  • Dr. Christof Weinstock (Ulm/ DE)

   Immunohematology
• 17:28 – 17:30 2 Min. 0 Min.

  • ePoster
  • PS-4-30

  Management of delivery of a woman with antibodies against high-prevalence red blood cell antigen Lan (Langereis) and von Willebrand disease

  • Dr. Stefanie Hammer (Tuebingen/ DE)
  • Dr. Yvonne Wanner (Tübingen/ DE)

   Immunohematology
• 17:30 – 17:32 2 Min. 0 Min.

  • ePoster
  • PS-4-31

  Advantages of targeted antenatal anti-D prophylaxis in RHD negative pregnant women

  • Dr. Natalija Lehner (Maribor/ SI)

   Immunohematology
• 17:32 – 17:34 2 Min. 0 Min.

  • ePoster
  • PS-4-32

  Monocytes subsets are responsible for anti-HPA-1a mediated platelet phagocytosis in blood

  • Judith Ratke (Giessen/ DE)

   Immunohematology
• 17:34 – 17:36 2 Min. 0 Min.

  • ePoster
  • PS-4-33

  Soluble CD177: A new allele for an old antigen

  • Stefanie Jehle (Giessen/ DE)
  • Yannick Waxmann (Giessen/ DE)

   Immunohematology
• 17:36 – 17:38 2 Min. 0 Min.

  • ePoster
  • PS-4-34

  Neonatal platelets loaded with anti-HPA-5b but no fetal/neonatal alloimmune thrombocytopenia (FNAIT): a case report

  • Dr. Nina Cooper (Giessen/ DE)

   Immunohematology
• 17:38 – 17:40 2 Min. 0 Min.

  • ePoster
  • PS-4-35

  Fetal and neonatal alloimmune thrombocytopenia: no evidence of systemic inflammation as a modulator of disease severity, but placental inflammation could be key

  • Prof. Dr. Ulrich Sachs (Giessen/ DE)

   Immunohematology
• 17:40 – 17:42 2 Min. 0 Min.

  • ePoster
  • PS-4-36

  Alpha-Methyldopa-induced autoimmune hemolytic anemia diagnosed after delivery

  • Mariam Sulimankhil (Hamburg/ DE)

   Immunohematology
• 17:42 – 17:44 2 Min. 0 Min.

  • ePoster
  • PS-4-37

  World Human Neutrophil Antigens (HNAs) Investigation Survey (WHIS)

  • Jonas Lowack (Giessen/ DE)

   Immunohematology
• 17:44 – 17:46 2 Min. 0 Min.

  • ePoster
  • PS-4-38

  Noninvasive fetal genotyping of red blood or platelet antigens using next generation sequencing – Experience of the last 8 years

  • Dr. Sandra Wienzek-Lischka (Giessen/ DE)

   Immunohematology
• 17:46 – 17:48 2 Min. 0 Min.

  • ePoster
  • PS-4-39

  Passenger lymphocyte syndrome – A rare cause of immunohematological problems and hemolysis after transplantation

  • Willi Francisco Speck (Berlin/ DE)
  • Genadi Gospodinov (Berlin/ DE)
  • PD Dr. Beate Mayer (Berlin/ DE)

   Immunohematology
• 17:48 – 17:50 2 Min. 0 Min.

  • ePoster
  • PS-4-40

  Case report of resolving a KEL1 genotype-phenotype discrepancy with full-gene haplotype sequencing by Oxford Nanopore Technologies

  • Dr. Gian Andri Thun (Schlieren/ CH)

   Immunohematology
• 17:50 – 17:52 2 Min. 0 Min.

  • ePoster
  • PS-4-41

  Case report of a rare JMH negative patient and detailed characterization with serological and molecular methods

  • Isabelle Rimke (Bad Kreuznach/ DE)

   Immunohematology
• 17:52 – 17:54 2 Min. 0 Min.

  • ePoster
  • PS-4-42

  Significant Neutropenia induced by Metamizole-dependent neutrophil antibodies

  • Stefanie Jehle (Giessen/ DE)

   Immunohematology